Navigation Links
Calixa Therapeutics Announces Positive Phase 1 Results for CXA-101, a Novel Intravenous Cephalosporin Antibiotic with Excellent Anti-Pseudomonal Activity
Date:3/23/2009

(exclude certain Asia-Pacific territories) to CXA-101 (FR264205) from Astellas Pharma Inc. in 2007. CXA-101's potent in vitro activity against Pseudomonas aeruginosa has the potential to address the unmet medical need posed by this very problematic gram-negative pathogen, which is a common cause of serious infection associated with high morbidity and mortality. Nonclinical studies have shown CXA-101 is highly active against multiple drug-resistant Pseudomonas aeruginosa, including many strains resistant to carbapenems, an antibiotic class generally considered as having the most potent activity against resistant gram-negative pathogens.

About Calixa Therapeutics

Calixa Therapeutics Inc. is a biopharmaceutical company committed to the development and commercialization of novel medicines for the treatment of infectious diseases. The company's initial focus is on developing novel antibiotics for use in the hospital setting. Calixa Therapeutics, which is privately held, is headquartered in San Diego and has operations in the San Francisco Bay Area. For additional information, please visit: www.calixainc.com.

    Contacts:

    Robert Flamm, Ph.D., or David Schull
    Russo Partners
    (212) 845-4226
    robert.flamm@russopartnersllc.com
    david.schull@russopartnersllc.com

    Eckard Weber, M.D.
    Calixa Therapeutics Inc.
    (858) 480-2420
    stone@domainvc.com


'/>"/>
SOURCE Calixa Therapeutics Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Oxygen Biotherapeutics, Inc. Receives Letter From FDA Outlining Path Forward to Resume Oxycyte Clinical Trials in TBI in U.S.A.
2. Alba Therapeutics Corporation Announces the Next Clinical Trial of Its Lead Compound, Larazotide Acetate and Promotions
3. InteKrin Therapeutics Announces Enrollment Completion of 360 Patient, 24 week Phase 2b Study
4. Ascenta Therapeutics Announces Positive Preliminary Results with AT-101 in Docetaxel Refractory Prostate Cancer
5. Amicus Therapeutics Suspends Enrollment for Phase 2 Clinical Trial of AT2220 for Pompe Disease
6. ExonHit Therapeutics Reports Advancements in the Clinical Development of EHT 0202, its Phase II Drug for Alzheimers Disease
7. BN ImmunoTherapeutics Updates on Phase I/II Studies With Breast Cancer Vaccine
8. Cell Therapeutics and IDIS Announce Agreement for a European Named Patient/Compassionate Use Program for Pixantrone
9. Cerenis Therapeutics In-Licenses Intellectual Property for New Treatment of Aortic Valve Stenosis
10. PTC Therapeutics Completes Enrollment of Pivotal Trial in Muscular Dystrophy
11. DNA Therapeutics Closes 2.2 Million EUR Series A Financing Round
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... and HOUSTON, TX , Feb. ... "Company") (TSX-V: EPI) and Bloom Burton & Co. Ltd. ... voluntary contractual lock-up (the "Lock-Up") 2,353,130 common shares of ... Shares originally subject to the Lock-Up. Of the Common ... free trading immediately upon release from the Lock-Up while ...
(Date:2/27/2015)... PRUSSIA, Pa. , Feb. 27, 2015  In ... its ongoing commitment to the global bleeding disorders community, ... donating 2 million international units (IUs) of protein therapies ... an international not-for- profit organization which has worked to ... inherited bleeding disorders. The donation supports the WFH,s Global ...
(Date:2/27/2015)... , Feb. 27, 2015  Uroplasty, Inc. (NASDAQ: ... and markets innovative proprietary products to treat voiding dysfunctions, ... Annual ROTH Conference on Tuesday, March 10, 2015. ... Reynolds , Chief Financial Officer, will present at 4:00 ... one at the conference at the Ritz Carlton in ...
Breaking Medicine Technology:ESSA Pharma and Bloom Burton announce additional release of shares from voluntary lock-up agreement 2ESSA Pharma and Bloom Burton announce additional release of shares from voluntary lock-up agreement 3ESSA Pharma and Bloom Burton announce additional release of shares from voluntary lock-up agreement 4CSL Behring Continues Treatment Access Leadership by Donating Bleeding Disorder Protein Therapies IUs to World Federation of Hemophilia 2CSL Behring Continues Treatment Access Leadership by Donating Bleeding Disorder Protein Therapies IUs to World Federation of Hemophilia 3Uroplasty to Participate in the 27th Annual ROTH Conference 2
... CAMBRIDGE, England, October 6 TCP Innovations, the Cambridge-based ... the opening of its first office in the United ... Principal Consultant, who will lead a growing team of ... to perform consulting projects for US clients. The US ...
... Reportlinker.com announces that a new market research ... Reportlinker Adds Gilead Sciences Inc.: ... , Introduction , This analysis examines ... in the prescription pharmaceutical sector. The profile ...
Cached Medicine Technology:TCP Innovations Opens First US Office 2Reportlinker Adds Gilead Sciences Inc.: PharmaVitae Profile 2Reportlinker Adds Gilead Sciences Inc.: PharmaVitae Profile 3Reportlinker Adds Gilead Sciences Inc.: PharmaVitae Profile 4
(Date:2/28/2015)... February 28, 2015 Vancouver personal injury lawyers ... claims are affected by time limits. They stated that in ... person’s claim or even nullify it. Many a time, delays ... a client’s rights under BC law. As a result, experts ... by accidents should consult a personal injury lawyer in order ...
(Date:2/28/2015)... For those people who are unable to ... Applied Research Foundation (Meso Foundation) will broadcast its ... at 9:30 AM. , The live broadcast is free ... be accessed through any browser on a computer or ... is a unique event that covers important treatment information ...
(Date:2/28/2015)... 2015 National Sales Solutions ... marketing and supply chain management for consumer packaged ... bringing its award winning solutions for thinning-damaged hair ... are specifically created to combat thinning-damaged hair. ... committed to marrying science with nature to create ...
(Date:2/28/2015)... 28, 2015 A case management conference ... that have been filed by law firms including Bernstein ... in March, the Firm notes. , According to ... in the federal litigation will meet on March 13, ... prescription therapy treatments designed to raise levels of the ...
(Date:2/28/2015)... On Thursday, February 26th, Forbes published an article titled ... Steal Your Data , which stresses the ease with which ... phishing kit, or any kind of malware kit for that ... about how everyone’s cyber security is intertwined when it covers ... content management systems or blogs in order to install the ...
Breaking Medicine News(10 mins):Health News:Jiwa Law Corporation Recently Announced That Time Delays May Weaken Personal Injury Claims 2Health News:Mesothelioma Cancer Research Foundation Broadcasting Symposium Live 2Health News:BIOTA Botanicals Brings Thinning-Damaged Hair Solutions to the Hair Care Aisle at Walgreens 2Health News:BIOTA Botanicals Brings Thinning-Damaged Hair Solutions to the Hair Care Aisle at Walgreens 3Health News:Bernstein Liebhard LLP Notes Approaching Conference in Federal Litigation that Includes Numerous Testosterone Lawsuits Filed by the Firm 2Health News:Bernstein Liebhard LLP Notes Approaching Conference in Federal Litigation that Includes Numerous Testosterone Lawsuits Filed by the Firm 3Health News:Bernstein Liebhard LLP Notes Approaching Conference in Federal Litigation that Includes Numerous Testosterone Lawsuits Filed by the Firm 4Health News:DIY Phishing and Malware Kits Make it Easy to Compromise Businesses in More Ways than One 2Health News:DIY Phishing and Malware Kits Make it Easy to Compromise Businesses in More Ways than One 3Health News:DIY Phishing and Malware Kits Make it Easy to Compromise Businesses in More Ways than One 4
... Encision Inc. (Amex:,ECI), a medical device company owning patented ... in minimally-invasive surgery, reported its,financial results for its third ... for the third quarter of fiscal year 2008, ended ... over net sales of,$2.79 million for the prior fiscal ...
... pro forma adjusted results include 16 percent sales growth and EPS of ... $.90, - Full-year results highlighted ... ... LLY ) today announced financial results for the fourth quarter and,full year of 2007., Throughout this ...
... MS -- Cold and flu season is upon us,affecting ... according to,the Centers for Disease Control. A cold is ... children and the elderly. Early detection,is key, especially since ... the infection,s onset., (Photo: http://www.newscom.com/cgi-bin/prnh/20080129/NYTUFNS1 ), ...
... American Academy,of Family Physicians is pleased that President Bush,s ... access to health care. In doing,so, the president has ... Improving Americans, ability to pay for health care is ... provides care to all, ensures the,financial viability of those ...
... Diet offers cholesterol lowering solution, SAN FRANCISCO, Jan. ... nurse practitioner in San Francisco, has been,helping patients lower ... focusing on the Apo E gene and advanced cholesterol ... disease," insists McDonald, "and it,doesn,t necessarily require a statin ...
... PROGRESS OF HEALTH REFORM IN CALIFORNIA, LOS ANGELES, ... CEO of The California Endowment, today issued the following ... achieving comprehensive health reform took a decidedly,disappointing step backward ... take action on the health reform package known as ...
Cached Medicine News:Health News:Encision Reports Third Fiscal Quarter Results 2Health News:Encision Reports Third Fiscal Quarter Results 3Health News:Lilly Caps Successful Year with Strong Fourth-Quarter Results 2Health News:Lilly Caps Successful Year with Strong Fourth-Quarter Results 3Health News:Lilly Caps Successful Year with Strong Fourth-Quarter Results 4Health News:Lilly Caps Successful Year with Strong Fourth-Quarter Results 5Health News:Lilly Caps Successful Year with Strong Fourth-Quarter Results 6Health News:Lilly Caps Successful Year with Strong Fourth-Quarter Results 7Health News:Lilly Caps Successful Year with Strong Fourth-Quarter Results 8Health News:Lilly Caps Successful Year with Strong Fourth-Quarter Results 9Health News:Lilly Caps Successful Year with Strong Fourth-Quarter Results 10Health News:Lilly Caps Successful Year with Strong Fourth-Quarter Results 11Health News:Lilly Caps Successful Year with Strong Fourth-Quarter Results 12Health News:Lilly Caps Successful Year with Strong Fourth-Quarter Results 13Health News:Lilly Caps Successful Year with Strong Fourth-Quarter Results 14Health News:Lilly Caps Successful Year with Strong Fourth-Quarter Results 15Health News:Lilly Caps Successful Year with Strong Fourth-Quarter Results 16Health News:Lilly Caps Successful Year with Strong Fourth-Quarter Results 17Health News:Lilly Caps Successful Year with Strong Fourth-Quarter Results 18Health News:Lilly Caps Successful Year with Strong Fourth-Quarter Results 19Health News:Lilly Caps Successful Year with Strong Fourth-Quarter Results 20Health News:Lilly Caps Successful Year with Strong Fourth-Quarter Results 21Health News:Lilly Caps Successful Year with Strong Fourth-Quarter Results 22Health News:Flu and Fever Detection Facts for Dr. Mom 2Health News:Flu and Fever Detection Facts for Dr. Mom 3Health News:AAFP Statement - Family Physicians to President Bush: Call for Improved Health Access is Only One Step to Comprehensive Reform 2Health News:AAFP Statement - Family Physicians to President Bush: Call for Improved Health Access is Only One Step to Comprehensive Reform 3Health News:New Gene-Based Therapy an Alternative to Vytorin and Statins in Heart Disease Prevention and Treatment 2
BRAT 2 Autologous Blood Recovery System gives performance, speed, versatility, and quality processing. , ,The BRAT 2 is now available with on-board Vacuum, programmability, plasma sequestration, Data...
... Like other blood salvage devices, the ... blood cells lost during and after surgery, ... its kind designed specifically to adapt to ... surgical patients. The system consists of single-patient ...
... Davol® pulsed lavage ... needed for quick, efficient ... bacteria, and foreign material. ... for optimal cleansing and ...
Stryker Instruments InterPulse System advances the ease and performance of battery powered irrigation for Orthopaedics, Trauma, and Wound Care....
Medicine Products: